Amlodipine attenuates oxidative stress in the heart and blood of high-cholesterol diet rabbits

Cardiovascular Journal of Africa

Volumn 23, Issue 1, 2012, Pages 18-22

  Salehi, I ^a   Mohammadi, M ^b   Mirzaei, F ^b   Soufi, F G ^c  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amlodipine; Cholesterol fed rabbits; Lipid peroxidation; Oxidation stress

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; AMLODIPINE; CHOLESTEROL; GLUTATHIONE PEROXIDASE; LIPID; LIQUID NITROGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID; TRIACYLGLYCEROL; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME ASSAY; FROZEN SECTION; HEART; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RABBIT; SUPERNATANT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DIET; DRUG EFFECTS;

AMLODIPINE; ANIMALS; ANTIOXIDANTS; CHOLESTEROL; DIET; HYPERCHOLESTEROLEMIA; OXIDATIVE STRESS; RABBITS;

EID: 84857254295     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2010-091     Document Type: Article

References (40)

1. Tsutsui H. Mitochondrial oxidative stress and heart failure. Intern Med 2006; 45: 809-813. (Pubitemid 44194346)
2. Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2007; 93: 903-907. (Pubitemid 47122034)
3. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 12: 159-163. (Pubitemid 15192863)
4. Siwik DA, Tzortzis JD, Pimental DR, et al. Inhibition of copperzinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 1999; 85: 147-153. (Pubitemid 29343313)
5. Ogunro PS, Balogun WO, Fadero FF, Idogun ES, Oninla SO, Elemile PO, Eziyi AK. Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease. West Afr J Med 2009; 28(2): 87-91.
6. Real JT, Martinez-Hervas S, Tormos MC, et al. Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia. Curr Pharm Des 2009; 15(26): 2988-3002.
7. Nieman B, Rohrbach S, Catar RA, Muller G, Barton M, Morawietz H. Native and oxidized LDL stimulate endothelin converting enzyme-1 expression in human endothelial cells. Biochem Biophys Res Commun 2005; 334: 747-753. (Pubitemid 41033185)
8. Stocker R, Keaney JF. Role of oxidative modification in atherosclerosis. Physiol Rev 2004; 84: 1381-1478.
9. Ascensao A, Ferreira R, Magalhaes J. Exercise-induced cardioprotection - biochemical, morphological and functional evidence in whole tissue and isolated mitochondria. Int J Cardiol 2007; 12; 117(1): 16-30.
10. Powers SK, Quindry JC, Kavazis AN. Exercise-induced cardioprotection against myocardial ischemia-reperfusion injury. Free Radic Biol Med 2008; 15; 44(2): 193-201.
11. Okuda N, Hayashi T, Mori T, et al. Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure. Hypertens Res 2005; 28: 431-438. (Pubitemid 41007458)
12. Packer M, O'Conner CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107-1114. (Pubitemid 26330964)
13. Hasegawa H, Takano H, Kohro T, et al. Amelioration of hypertensive heart failure by amlodipine may occur via antioxidative effects. Hyper tens Res 2006; 29: 719-729.
14. Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, Williams RS. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 2000; 275: 8719-8725. (Pubitemid 30180224)
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1979; 72: 248-254.
16. Draper HH, Hadley M. Malondialdeyde determination as an index of lipid peroxidation. Meth Enzym 1990; 186: 421-431. (Pubitemid 20279983)
17. Delmas-Beauvieux MC, Peuchant E, Dumon MF, Receuver MC, Le Bras M, Clerc M. Relationship between red cell antioxidant enzymatic system status and lipid peroxidation during the acute phase of malaria. Clin Biochem 1995; 28: 163-169.
18. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
19. Chong TZ, Yang SP, Pei D. Amlodipine inhibits pro-inflammation cytokines and free radical production and inducible nitric oxide synthase expression in lipopolysaccharide/interferon γ stimulated cultured vascular smooth muscle cells. JJP 2002; 89: 157-163. (Pubitemid 34752301)
20. Mancini GB. Antiatherosclerotic effects of calcium channel blockers. Prog Cardiovasc Dis 2002; 45: 1-2
21. Mason RP, Marche P, Hintze TH. Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine. Arterioscler Thromb Vasc Biol 2003; 23: 2155-2163. (Pubitemid 37532314)
22. Pereira B, Costa Rosa Lf, Safi DA, Medeiros MH, Curi R. Superoxide dismutase, catalase, and glutathione peroxidase activities in muscle and lymphoid organs of sedentary and exercise-trained rats. Physiol Behav 1994; 56: 1095-1099. (Pubitemid 24337131)
23. Sharrett, AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104: 1108-1113. (Pubitemid 32830392)
24. Wang M, Briggs MR. HDL: the metabolism, function, and therapeutic importance. Chem Rev 2004; 104: 119-137.
25. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-2551. (Pubitemid 23182507)
26. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radical Biol Med 1991; 11: 81-128. (Pubitemid 121003917)
27. Kutuk O, Basaga H. Inflammation meets oxidation: NF-κB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med 2003; 9: 549-557. (Pubitemid 38017194)
28. Jung HH, Choi DH, Lee SH. Serum malondialdehyde and coronary artery disease in hemodialysis patients. Am J Nephrol 2004; 24: 537-542. (Pubitemid 39656669)
29. Mogi M, Iwai M, Chen R, et al. Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice. Am J Hypertens 2006; 19: 1144-1149. (Pubitemid 44633592)
30. Umemoto S, Kawahara S, Hashimoto R, et al. Different effects of amlodipine and enalapril on the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway for induction of vascular smooth muscle cell differentiation in vivo. Hypertens Res 2006; 29: 179-186.
31. Meilhac O, Ramachandran S, Chiang K, Santanam N, Parthasarathy S. Role of arterial wall antioxidant defense in beneficial effects of exercise on atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2001; 21: 1681-1688. (Pubitemid 34215591)
32. Barry-Lane PA, Patterson C, van der Merwe M, et al. p47phox is required for atherosclerotic lesion progression in ApoE-/-mice. J Clin Invest 2001; 108: 1513-1522 (Pubitemid 33091989)
33. Lundy A, Lutfi N, Beckey C. Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension. Vasc Health Risk Manag 2009; 5: 429-440.
34. Umemoto S, Tanaka M, Kawahara S, et al. Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27: 877-885. (Pubitemid 40309454)
35. Ushio-Fukai M, Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: role of NADPH oxidase. Mol Cell Biochem 2004; 264: 85-97. (Pubitemid 39366107)
36. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 29-38. (Pubitemid 40054251)
37. 2-induced cell death in neonatal rat cardiomyocytes. Cardiovasc Drugs Ther 2007; 21: 69-72.
38. Masumoto K, Takeyasu A, Oizumi K, Kobayashi T. Studies of novel 1,4-dihydropyridine Ca antagonist CS-905. I. Measurement of partition coefficient (log P) by high performance liquid chromatography (HPLC). Yakugaku Zasshi 1995; 115: 213-220.
39. Tanaka T, Nangaku M, Miyata T, et al. Blockade of calcium influx through L-type calcium channels attenuates mitochondrial injury and apoptosis in hypoxic renal tubular cells. J Am Soc Nephrol 2004; 15: 2320-2333. (Pubitemid 39159332)
40. Candido R, Allen TJ, Lassila M, et al. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 2004; 109: 1536-1542. (Pubitemid 38420183)